Abstract
High doses of intrathecally applied morphine or morphine-3β-d-glucuronide (M3G) produce allodynia and hyperalgesia. Whole-cell patch-clamp recordings were made from substantia gelatinosa neurons in transverse slices of adult rat lumbar spinal cord to compare the actions of M3G with those of the μ-opioid agonist, DAMGO ([d-Ala2,N-Met-Phe4,Gly-ol5]-enkephalin), and the ORL1 agonist, nociceptin/orphanin FQ (N/OFQ). M3G (1–100 μM) had little or no effect on evoked excitatory postsynaptic currents (EPSC) and no effect on postsynaptic membrane conductance. In contrast, 1 μM DAMGO and 1 μM N/OFQ reduced the amplitude of evoked EPSCs and activated an inwardly rectifying K+ conductance. M3G did not attenuate the effect of DAMGO or N/OFQ on evoked EPSC amplitude. However, 1 to 100 μM M3G reduced the amplitude of evoked GABAergic and glycinergic inhibitory postsynaptic current (IPSC) by up to 48%. This effect was naloxone-insensitive. The evoked IPSC was also attenuated by DAMGO, but not by N/OFQ. Because M3G reduced the frequency of tetrodotoxin-insensitive miniature IPSCs and increased paired-pulse facilitation, it appeared to act presynaptically to disinhibit substantia gelatinosa neurons. This effect, which does not appear to involve μ-opioid or ORL1 receptors, may contribute to the allodynia and hyperalgesia observed after intrathecal application of high doses of morphine.
Footnotes
-
The Canadian Institutes of Health Research (CIHR), the Rick Hansen Neurotrauma Initiative, and the Alberta Heritage Foundation for Medical Research supported this work. T.D.M. was supported by a studentship from the CIHR.
-
DOI: 10.1124/jpet.102.035626
- Abbreviations:
- M3G
- morphine-3β-d-glucuronide
- M6G
- morphine-6β-d-glucuronide
- GABA
- γ-aminobutyric acid
- AP5
- dl-2-amino-5-phosphonovaleric acid
- CNQX
- 6-cyano-7-nitroquinoxaline-2,3-dione
- DAMGO
- [d-Ala2,N-Met-Phe4,Gly-ol5]-enkephalin
- EPSC
- excitatory postsynaptic current
- IPSC
- inhibitory postsynaptic current
- mIPSC
- miniature IPSC
- N/OFQ
- nociceptin/orphanin FQ
- TTX
- tetrodotoxin
- HPLC
- high-performance liquid chromatography
- CSF
- cerebrospinal fluid
- QX-314
- N-(2,6-dimethylphenyl)acetamide-2-triethylammonium bromide
- Received February 28, 2002.
- Accepted April 24, 2002.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|